Literature DB >> 30054309

Highly cytotoxic natural killer cells are associated with poor prognosis in patients with cutaneous T-cell lymphoma.

Bethany Mundy-Bosse1,2, Nathan Denlinger1, Eric McLaughlin3, Nitin Chakravarti4, Susan Hwang1, Li Chen2, Hsiaoyin Charlene Mao2, David Kline3, Youssef Youssef5, Rebecca Kohnken6, Dean Anthony Lee4, Gerard Lozanski5, Aharon G Freud2,5, Pierluigi Porcu7, Basem William1, Michael A Caligiuri1,2, Anjali Mishra2,8.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 30054309      PMCID： PMC6093742          DOI： 10.1182/bloodadvances.2018020388

Source DB:  PubMed          Journal:  Blood Adv        ISSN： 2473-9529


× No keyword cloud information.
  40 in total

1.  miR-155 regulates IFN-γ production in natural killer cells.

Authors:  Rossana Trotta; Li Chen; David Ciarlariello; Srirama Josyula; Charlene Mao; Stefan Costinean; Lianbo Yu; Jonathan P Butchar; Susheela Tridandapani; Carlo M Croce; Michael A Caligiuri
Journal:  Blood       Date:  2012-02-29       Impact factor: 22.113

2.  CTLA-4 is expressed by activated mouse NK cells and inhibits NK Cell IFN-γ production in response to mature dendritic cells.

Authors:  Ana Stojanovic; Nathalie Fiegler; Monika Brunner-Weinzierl; Adelheid Cerwenka
Journal:  J Immunol       Date:  2014-03-31       Impact factor: 5.422

Review 3.  Sézary Syndrome: Clinical and Biological Aspects.

Authors:  Rebecca Kohnken; Stephanie Fabbro; Justin Hastings; Pierluigi Porcu; Anjali Mishra
Journal:  Curr Hematol Malig Rep       Date:  2016-12       Impact factor: 3.952

Review 4.  The role of Stat5a and Stat5b in signaling by IL-2 family cytokines.

Authors:  J X Lin; W J Leonard
Journal:  Oncogene       Date:  2000-05-15       Impact factor: 9.867

5.  Depletion of M2-like tumor-associated macrophages delays cutaneous T-cell lymphoma development in vivo.

Authors:  Xuesong Wu; Brian C Schulte; Youwen Zhou; Dipica Haribhai; Alexander C Mackinnon; Jose A Plaza; Calvin B Williams; Sam T Hwang
Journal:  J Invest Dermatol       Date:  2014-04-29       Impact factor: 8.551

6.  Circulating natural killer lymphocytes are potential cytotoxic effectors against autologous malignant cells in sezary syndrome patients.

Authors:  Jean-David Bouaziz; Nicolas Ortonne; Jérôme Giustiniani; Valérie Schiavon; Delphine Huet; Martine Bagot; Armand Bensussan
Journal:  J Invest Dermatol       Date:  2005-12       Impact factor: 8.551

7.  Natural and concanavalin A-induced cytotoxic activity towards continuously growing B lymphocytes derived from patients with cutaneous T-cell lymphoma.

Authors:  J R Jensen; K Kaltoft; S Bisballe; K Thestrup-Pedersen
Journal:  Arch Dermatol Res       Date:  1986       Impact factor: 3.017

8.  Tumor-associated M2 macrophages in mycosis fungoides acquire immunomodulatory function by interferon alpha and interferon gamma.

Authors:  Sadanori Furudate; Taku Fujimura; Aya Kakizaki; Takanori Hidaka; Masayuki Asano; Setsuya Aiba
Journal:  J Dermatol Sci       Date:  2016-06-08       Impact factor: 4.563

9.  Mechanism, Consequences, and Therapeutic Targeting of Abnormal IL15 Signaling in Cutaneous T-cell Lymphoma.

Authors:  Anjali Mishra; Krista La Perle; Sonya Kwiatkowski; Laura A Sullivan; Gregory H Sams; Jessica Johns; Douglas P Curphey; Jing Wen; Kathleen McConnell; Jun Qi; Henry Wong; Giandomenico Russo; Jianying Zhang; Guido Marcucci; James E Bradner; Pierluigi Porcu; Michael A Caligiuri
Journal:  Cancer Discov       Date:  2016-07-15       Impact factor: 39.397

10.  The possible interaction between periostin expressed by cancer stroma and tumor-associated macrophages in developing mycosis fungoides.

Authors:  Sadanori Furudate; Taku Fujimura; Aya Kakizaki; Yumi Kambayashi; Masayuki Asano; Akiko Watabe; Setsuya Aiba
Journal:  Exp Dermatol       Date:  2015-11-23       Impact factor: 3.960
View more
  5 in total

1.  Immune signatures of CD4 and CD68 predicts disease progression in cutaneous T cell lymphoma.

Authors:  Sanling Huang; Mengying Liao; Siliang Chen; Ping Zhang; Fangzhou Xu; Hongyu Zhang
Journal:  Am J Transl Res       Date:  2022-05-15       Impact factor: 3.940

Review 2.  The immune contexture and Immunoscore in cancer prognosis and therapeutic efficacy.

Authors:  Daniela Bruni; Helen K Angell; Jérôme Galon
Journal:  Nat Rev Cancer       Date:  2020-08-04       Impact factor: 60.716

Review 3.  NK Cells in the Treatment of Hematological Malignancies.

Authors:  Ana P Gonzalez-Rodriguez; Mónica Villa-Álvarez; Christian Sordo-Bahamonde; Seila Lorenzo-Herrero; Segundo Gonzalez
Journal:  J Clin Med       Date:  2019-09-27       Impact factor: 4.241

4.  Interleukin-15 in cancer immunotherapy: IL-15 receptor complex versus soluble IL-15 in a cancer cell-delivered murine leukemia model.

Authors:  Alexandra Berger; Sarah J Colpitts; Melanie S S Seabrook; Caren L Furlonger; Maura B Bendix; Joshua M Moreau; William M McKillop; Jeffrey A Medin; Christopher J Paige
Journal:  J Immunother Cancer       Date:  2019-12-19       Impact factor: 13.751

Review 5.  The Biological Role and Therapeutic Potential of NK Cells in Hematological and Solid Tumors.

Authors:  Rodion A Velichinskii; Maria A Streltsova; Sofya A Kust; Alexander M Sapozhnikov; Elena I Kovalenko
Journal:  Int J Mol Sci       Date:  2021-10-21       Impact factor: 5.923
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.